HCPList Know more before you call. About
A DIFFERENT WAY TO EXPLORE

Similar work.
More providers to explore.

Compare the published Medicare service mix of Jacinth Joseph, M.D. with clinicians in the same registry specialty: Hematology/Oncology · Internal Medicine (CMS).

DALLAS, TX · Exact areaEdit location

2024 published service data · 81 eligible profiles compared. Similarity describes billing patterns, not quality, outcomes, or suitability for your care.

Vikas Bhushan, M.D.

Hematology/Oncology · Internal Medicine · Medical Oncology (CMS) · Dallas, TX

Shared published services
3 shared services · view billing descriptions
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes (99233)
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes (99232)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (96401)
60%Service-mix similarityView profile →

Nebu V Koshy, M.D.

Hematology/Oncology · Medical Oncology (CMS) · Dallas, TX

Shared published services
3 shared services · view billing descriptions
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes (99233)
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes (99232)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (96401)
57%Service-mix similarityView profile →

Dai Chu Nguyen Luu, MD

Hematology/Oncology · Internal Medicine · Medical Oncology (CMS) · Dallas, TX

Shared published services
3 shared services · view billing descriptions
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes (99233)
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes (99232)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (96401)
57%Service-mix similarityView profile →

Jivesh J Sharma, MD

Hematology · Medical Oncology (CMS) · Dallas, TX

Shared published services
3 shared services · view billing descriptions
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes (99233)
  • Injection of additional new drug or substance into vein (96375)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (96365)
57%Service-mix similarityView profile →

Antoinette Matthews, M.D.

Hematology/Oncology · Internal Medicine · Medical Oncology (CMS) · Dallas, TX

Shared published services
3 shared services · view billing descriptions
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes (99232)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (96401)
  • Injection of additional new drug or substance into vein (96375)
56%Service-mix similarityView profile →

Christopher Marc Maisel, MD

Hematology/Oncology · Internal Medicine · Medical Oncology (CMS) · Dallas, TX

Shared published services
3 shared services · view billing descriptions
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes (99233)
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes (99232)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (96401)
56%Service-mix similarityView profile →

Estil August Vance, M.D.

Infectious Disease · Internal Medicine · Medical Oncology (CMS) · Dallas, TX

Shared published services
3 shared services · view billing descriptions
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes (99232)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (96401)
  • Injection of additional new drug or substance into vein (96375)
55%Service-mix similarityView profile →

Luis Pineiro, MD

Hematology/Oncology · Internal Medicine (CMS) · Dallas, TX

Shared published services
3 shared services · view billing descriptions
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes (99233)
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes (99232)
  • Injection of additional new drug or substance into vein (96375)
55%Service-mix similarityView profile →

Yvonne Marie Coyle, MD

Hematology/Oncology · Internal Medicine · Medical Oncology (CMS) · Dallas, TX

Shared published services
3 shared services · view billing descriptions
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes (99233)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (96401)
  • Injection of additional new drug or substance into vein (96375)
55%Service-mix similarityView profile →

Bradley Christensen, MD

Internal Medicine (CMS) · Dallas, TX

Shared published services
3 shared services · view billing descriptions
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes (99233)
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes (99232)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (96401)
54%Service-mix similarityView profile →

Katherine Chiyu Wang, MD, PHD

Hematology/Oncology · Hospice/Palliative Care · Medical Oncology (CMS) · Dallas, TX

Shared published services
3 shared services · view billing descriptions
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes (99232)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (96401)
  • Injection of additional new drug or substance into vein (96375)
52%Service-mix similarityView profile →

Racha Halawi, M.D., M.S.

Hematology/Oncology · Internal Medicine · Medical Oncology (CMS) · Dallas, TX

Shared published services
3 shared services · view billing descriptions
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes (99233)
  • Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes (99232)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (96401)
52%Service-mix similarityView profile →
How this comparison works

We use the same calendar year of CMS Medicare Physician & Other Practitioners data for both providers. Published non-drug service counts are combined by HCPCS code across places of service. We apply log(1 + count), normalize the vectors, and compare them using cosine similarity.

Candidates share the reference provider’s current NPPES primary taxonomy and match the location you enter. We examine up to 500 candidates in NPI order, then show up to 12 with the highest positive similarity within that set. The score is not a percentile, medical recommendation, or prediction. Suppressed services are not estimated. Medicare fee-for-service data does not describe a provider’s entire practice.

Source: CMS Medicare Physician & Other Practitioners - by Provider and Service : 2024-12-01 · Published May 21, 2026.